On the other hand, BDNF has been reported to stimulate receptor activator of nuclear factor kappa B ligand (RANKL) production from osteoblasts (OBs), thereby contributing to the formation of osteolytic bone lesions from multiple myeloma [21, 22]. Here, BDNF is linked to plasma cell myeloma.